New York-based KKR sells 7.5M shares in PRA Health Sciences
New York-based buyout firm Kohlberg Kravis Roberts & Co. Fund Holdings L.P. has sold 7.5 million shares of Raleigh-based PRA Health Sciences, according to a filing with the Securities and Exchange Commission. KKR sold the 7.5 million shares at a price of $55.51 each, profiting approximately $416.32 million from the sale. The firm now owns 22.7 million shares of PRA. The sale took place on Nov. 16. PRA Health Sciences is a contract research organization that specializes in producing, testing and developing pharmaceutical drugs. PRA’s own Chief Executive Officer Colin Shannon sold 113,133 shares of PRA stock back on...
Read More